THE USE OF SINGLE-SAMPLE CLEARANCE ESTIMATES TO PROBE HEPATIC DRUG-METABOLISM IN RATS .4. A MODEL FOR POSSIBLE APPLICATION TO PHENOTYPING XENOBIOTIC INFLUENCES ON HUMAN DRUG-METABOLISM

被引:11
作者
BACHMANN, KA
机构
关键词
D O I
10.3109/00498258909043195
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1449 / 1459
页数:11
相关论文
共 29 条
[1]   USING SINGLE CLEARANCE ESTIMATES TO PROBE HEPATIC DRUG-METABOLISM IN RATS - ETHOSUXIMIDE DISPOSITION KINETICS IN RATS [J].
BACHMANN, K ;
JAHN, D ;
YANG, C ;
SCHWARTZ, J .
XENOBIOTICA, 1988, 18 (04) :373-380
[2]  
BACHMANN K, 1988, XENOBIOTICA, V18, P149
[3]  
BACHMANN KA, 1988, XENOBIOTICA, V18, P161, DOI 10.3109/00498258809041652
[4]  
BAILLE T, 1989, XENOBIOTICA, V14, P151
[5]  
BURKE MD, 1987, DRUG METABOLISM MOL, P219
[6]  
CONNEY A, 1967, PHARMACOL REV, V36, P317
[8]   FLUORESCENCE POLARIZATION IMMUNOASSAY - THEORY AND EXPERIMENTAL METHOD [J].
DANDLIKER, WB ;
KELLY, RJ ;
DANDLIKER, J ;
FARQUHAR, J ;
LEVIN, J .
IMMUNOCHEMISTRY, 1973, 10 (04) :219-227
[9]  
DICKINSON RG, 1979, J PHARMACOL EXP THER, V211, P583
[10]   A SIMPLE METHOD FOR DETERMINATION OF ANTIPYRINE CLEARANCE [J].
DOSSING, M ;
POULSEN, HE ;
ANDREASEN, PB ;
TYGSTRUP, N .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) :392-396